Viewing Study NCT04507503

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:44 PM
Ignite Modification Date: 2026-01-24 @ 5:27 PM
Study NCT ID: NCT04507503
Status: APPROVED_FOR_MARKETING
Last Update Posted: 2025-01-07
First Post: 2020-08-07
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Expanded Access Study of TAS-120 in Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements
Sponsor: Taiho Oncology, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Cholangiocarcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cholangiocarcinoma View
None CCA View
None FGFR2 Gene Rearrangements View
None TAS-120 View
None Futibatinib View